Search market news

Elis reports third-quarter 2026 revenue growth acceleration

Elis says growth accelerated in the third quarter of 2026; no revenue figure is provided.

Elis Reports Third-Quarter 2026 Revenue

Neptune Insurance Reports Q3 Revenue Growth, Raises 2026 Guidance

Neptune Insurance reported Q3 revenue up 34% year over year to $59.6 million and adjusted EBITDA up 38% to $36.8 million. It raised 2026 guidance to $204 million in revenue and an adjusted EBITDA margin above 61%, and forecast 2027 revenue of $238 million.

Marsh Reports 8% Q3 Revenue Growth and Raises Savings Target

Marsh said third-quarter revenue rose 8% to $6.9 billion, underlying revenue growth was 5%, and adjusted EPS increased 10% to $2.03. The company raised its Thrive program savings target to $600 million from $400 million.

Maravai LifeSciences Reports Q2 Revenue Growth, Raises EBITDA Guidance

Maravai reported Q2 2026 revenue of $51.4 million, up 9% year over year, and adjusted EBITDA of $8.7 million. It maintained 2026 revenue guidance at $205 million to $215 million and raised adjusted EBITDA guidance to $33 to $35 million.

CarGurus Reports Q2 Revenue Growth of 13% to $251 Million

CarGurus reported second-quarter 2026 revenue of $251 million, up 13% year over year, and adjusted EBITDA of $85 million, up 7%. The company maintained full-year revenue growth guidance of 10% to 13% and raised its profitability outlook, expecting 2026 adjusted EBITDA margins to compress 50 to 150 basis points versus 2

AB Science reports first-half 2026 loss and cuts trials

AB Science reported a first-half 2026 net loss and said it is revising its clinical plan after a GCP inspection. The company also said it is discontinuing three non-priority studies.

REG — India CapitalGrwthFd — Interim Results for six months ended 30 June 2026

For best results when printing this announcement, please click on link below: RNS Number: 0602W India Capital Growth Fund Limited 24 September 2026 INDIA CAPITAL GROWTH FUND LIMITED Interim Results for the six months ended 30 June 2026 24 September 2026, London - India Capital Growth Fund ("ICGF" or "the Company"), the

Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript

Health Catalyst (NASDAQ: HCAT ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Health Catalyst exceeded revenue and adjusted

UiPath posts 12% ARR growth in 2027, fourth straight GAAP profit

UiPath reported second-quarter ARR up 12% to $1.938 billion and revenue up 13% to $410 million, with a fourth consecutive quarter of GAAP profitability and non-GAAP operating margin expanding to 22%.

Concentrix Reports Q2 2026 Results: Full Earnings Call Transcript

On Monday, Concentrix (NASDAQ: CNXC ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Concentrix reported record contract signings f